244 related articles for article (PubMed ID: 23283371)
21. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion.
Majid K; Tseng MD; Baker KC; Reyes-Trocchia A; Herkowitz HN
Spine J; 2011 Jun; 11(6):560-7. PubMed ID: 20097616
[TBL] [Abstract][Full Text] [Related]
22. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
Fox J; Miller MA; Recker RR; Turner CH; Smith SY
Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
[TBL] [Abstract][Full Text] [Related]
23. RhBMP-2-loaded calcium silicate/calcium phosphate cement scaffold with hierarchically porous structure for enhanced bone tissue regeneration.
Zhang J; Zhou H; Yang K; Yuan Y; Liu C
Biomaterials; 2013 Dec; 34(37):9381-92. PubMed ID: 24044997
[TBL] [Abstract][Full Text] [Related]
24. Healing of rat femoral segmental defect with bone morphogenetic protein-2: a dose response study.
Angle SR; Sena K; Sumner DR; Virkus WW; Virdi AS
J Musculoskelet Neuronal Interact; 2012 Mar; 12(1):28-37. PubMed ID: 22373949
[TBL] [Abstract][Full Text] [Related]
25. Union of a chronically infected internally stabilized segmental defect in the rat femur after debridement and application of rhBMP-2 and systemic antibiotic.
Chen X; Schmidt AH; Mahjouri S; Polly DW; Lew WD
J Orthop Trauma; 2007; 21(10):693-700. PubMed ID: 17986886
[TBL] [Abstract][Full Text] [Related]
26. New QCT analysis approach shows the importance of fall orientation on femoral neck strength.
Carpenter RD; Beaupré GS; Lang TF; Orwoll ES; Carter DR;
J Bone Miner Res; 2005 Sep; 20(9):1533-42. PubMed ID: 16059625
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primates.
Herford AS; Lu M; Buxton AN; Kim J; Henkin J; Boyne PJ; Caruso JM; Rungcharassaeng K; Hong J
J Oral Maxillofac Surg; 2012 Mar; 70(3):703-16. PubMed ID: 21549480
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits.
Luppen CA; Blake CA; Ammirati KM; Stevens ML; Seeherman HJ; Wozney JM; Bouxsein ML
J Bone Miner Res; 2002 Feb; 17(2):301-10. PubMed ID: 11811561
[TBL] [Abstract][Full Text] [Related]
29. The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis.
Liporace FA; Breitbart EA; Yoon RS; Doyle E; Paglia DN; Lin S
J Orthop Traumatol; 2015 Jun; 16(2):151-9. PubMed ID: 25421865
[TBL] [Abstract][Full Text] [Related]
30. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
Sato M; Zeng GQ; Turner CH
Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
[TBL] [Abstract][Full Text] [Related]
31. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
Boyne PJ
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
[TBL] [Abstract][Full Text] [Related]
32. Calcium Sulphate/Hydroxyapatite Carrier for Bone Formation in the Femoral Neck of Osteoporotic Rats.
Širka A; Raina DB; Isaksson H; Tanner KE; Smailys A; Kumar A; Tarasevičius Š; Tägil M; Lidgren L
Tissue Eng Part A; 2018 Dec; 24(23-24):1753-1764. PubMed ID: 29855219
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
Lee JH; Yu CH; Yang JJ; Baek HR; Lee KM; Koo TY; Chang BS; Lee CK
Spine J; 2012 Mar; 12(3):239-48. PubMed ID: 22341396
[TBL] [Abstract][Full Text] [Related]
34. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates.
Hanisch O; Tatakis DN; Rohrer MD; Wöhrle PS; Wozney JM; Wikesjö UM
Int J Oral Maxillofac Implants; 1997; 12(6):785-92. PubMed ID: 9425759
[TBL] [Abstract][Full Text] [Related]
35. Periodontal repair in dogs: evaluation of a bioresorbable calcium phosphate cement (Ceredex) as a carrier for rhBMP-2.
Sorensen RG; Wikesjö UM; Kinoshita A; Wozney JM
J Clin Periodontol; 2004 Sep; 31(9):796-804. PubMed ID: 15312104
[TBL] [Abstract][Full Text] [Related]
36. Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab.
Ominsky MS; Libanati C; Niu QT; Boyce RW; Kostenuik PJ; Wagman RB; Baron R; Dempster DW
J Bone Miner Res; 2015 Jul; 30(7):1280-9. PubMed ID: 25684625
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid treatment of ovariectomized sheep affects mineral density, structure, and mechanical properties of cancellous bone.
Schorlemmer S; Gohl C; Iwabu S; Ignatius A; Claes L; Augat P
J Bone Miner Res; 2003 Nov; 18(11):2010-5. PubMed ID: 14606514
[TBL] [Abstract][Full Text] [Related]
38. Local rhBMP-2 injection after drill-hole injury in rats: does it have systemic effects?
Demirkan N; Demirkan F; Aksoy A; Ozdemir M; Akman A
Int J Immunopathol Pharmacol; 2014; 27(2):253-60. PubMed ID: 25004837
[TBL] [Abstract][Full Text] [Related]
39. In vivo banking for vascularized autograft bone by intramuscular inoculation of recombinant human bone morphogenetic protein-2 and beta-tricalcium phosphate.
Chen WJ; Jingushi S; Jingushi K; Iwamoto Y
J Orthop Sci; 2006 May; 11(3):283-8. PubMed ID: 16721531
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons.
Miranda DA; Blumenthal NM; Sorensen RG; Wozney JM; Wikesjö UM
J Periodontol; 2005 Feb; 76(2):210-20. PubMed ID: 15974844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
